We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

82 hedge funds and large institutions have $179M invested in VanEck Biotech ETF in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $911K

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

4% more funds holding

Funds holding: 79 → 82 (+3)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

8.02% less ownership

Funds ownership: 34.65% → 26.63% (-8%)

28% less capital invested

Capital invested by funds: $249M → $179M (-$69.4M)

Holders
82
Holders Change
+3
Holders Change %
+3.8%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
24
Closed
11
Calls
$1.48M
Puts
$911K
Net Calls
+$572K
Net Calls Change
-$2.84M

Top Buyers

1
CG
Colony Group
Massachusetts
+$5.02M
2
TC
Trust Company
Kansas
+$4.39M
3
WI
WBI Investments
New Jersey
+$2.67M
4
OLA
Oliver Luxxe Assets
New Jersey
+$1.61M
5
ECM
Endurant Capital Management
California
+$1.42M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$51.7M
2
UBS Group
UBS Group
Switzerland
-$13.7M
3
Creative Planning
Creative Planning
Kansas
-$2.42M
4
AL
Aspiriant LLC
California
-$2.13M
5
PAG
Private Advisor Group
New Jersey
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
51
PNC Financial Services Group
Pennsylvania
$268K +$128 +1 +0%
LTFS
52
Ladenburg Thalmann Financial Services
Florida
$253K -$355K -2,779 -58%
TSS
53
Two Sigma Securities
New York
$243K +$249K +1,947 New
CAM
54
Covenant Asset Management
New Jersey
$236K +$242K +1,892 New
BRWA
55
B. Riley Wealth Advisors
Florida
$229K +$25.9K +203 +12%
FANJ
56
Financial Architects (New Jersey)
New Jersey
$210K +$11.7K +92 +6%
BRF
57
B. Riley Financial
California
$202K – – –
AG
58
Advisor Group
Arizona
$181K +$28.2K +221 +18%
EDRH
59
Edmond de Rothschild Holding
Switzerland
$142K -$58.7K -460 -29%
TC
60
Telemus Capital
Michigan
$128K +$132K +1,030 New
Citigroup
61
Citigroup
New York
$100K – – –
CPIG
62
Chicago Partners Investment Group
Illinois
$75K +$76.6K +600 New
KTC
63
Kistler-Tiffany Companies
Pennsylvania
$66K +$255 +2 +0.4%
RAM
64
Riggs Asset Management
Pennsylvania
$54K – – –
FAAS
65
First Allied Advisory Services
California
$53K -$151K -1,185 -73%
NSIM
66
North Star Investment Management
Illinois
$44K +$2.55K +20 +6%
KPCM
67
Kings Point Capital Management
New York
$34K – – –
AF
68
Arrow Financial
New York
$31K – – –
PRS
69
Pinkerton Retirement Specialists
Idaho
$30K – – –
AIP
70
Ameritas Investment Partners
Nebraska
$29K – – –
M
71
MOTCO
Texas
$25K – – –
AIM
72
Anchor Investment Management
South Carolina
$19.3K – – –
US Bancorp
73
US Bancorp
Minnesota
$19K – – –
APA
74
American Portfolios Advisors
New York
$12.5K +$12.8K +100 New
JP Morgan Chase
75
JP Morgan Chase
New York
$12K -$4.34K -34 -26%
1 2
3
4

BBH Hedge Fund Activity: Q4 2017 in Review

82 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2017, worth a combined $179M — down 28% from $249M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BBH positions and 11 closed out — a net gain of 3 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was Colony Group, opening a new position worth an estimated $5.02M. The largest seller was AllianceBernstein, cutting an estimated $51.7M.

  • 82 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2017, up from 79 in Q3 2017.
  • Funds reported $179M of VanEck Biotech ETF stock for Q4 2017, down 28% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q4 2017 and 11 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2017 was Colony Group, an estimated $5.02M added.
  • The largest VanEck Biotech ETF seller in Q4 2017 was AllianceBernstein, an estimated $51.7M sold.

Based on aggregated 13F filings for Q4 2017.